ZA200402859B - Differentially expressed genes associated with obesity and type 2 diabetes. - Google Patents

Differentially expressed genes associated with obesity and type 2 diabetes.

Info

Publication number
ZA200402859B
ZA200402859B ZA200402859A ZA200402859A ZA200402859B ZA 200402859 B ZA200402859 B ZA 200402859B ZA 200402859 A ZA200402859 A ZA 200402859A ZA 200402859 A ZA200402859 A ZA 200402859A ZA 200402859 B ZA200402859 B ZA 200402859B
Authority
ZA
South Africa
Prior art keywords
obesity
diabetes
type
differentially expressed
expressed genes
Prior art date
Application number
ZA200402859A
Inventor
Greg Collier
Ken Walder
Andrea Michelle De Silva
Paul Zev Zimmet
Janine Mcmillan
Kelly Windmill
Original Assignee
Autogen Res Pty Ltd
Internat Diabetes Inst And Dea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autogen Res Pty Ltd, Internat Diabetes Inst And Dea filed Critical Autogen Res Pty Ltd
Publication of ZA200402859B publication Critical patent/ZA200402859B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
ZA200402859A 2001-10-16 2004-04-15 Differentially expressed genes associated with obesity and type 2 diabetes. ZA200402859B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33014901P 2001-10-16 2001-10-16

Publications (1)

Publication Number Publication Date
ZA200402859B true ZA200402859B (en) 2005-01-24

Family

ID=23288511

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200402859A ZA200402859B (en) 2001-10-16 2004-04-15 Differentially expressed genes associated with obesity and type 2 diabetes.

Country Status (9)

Country Link
EP (1) EP1446414A4 (en)
JP (1) JP2005510214A (en)
KR (1) KR20040088019A (en)
CN (1) CN1596264A (en)
CA (1) CA2463578A1 (en)
IL (1) IL161294A0 (en)
MX (1) MXPA04003635A (en)
WO (1) WO2003033513A1 (en)
ZA (1) ZA200402859B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513300A1 (en) * 2003-01-13 2004-07-29 Autogen Research Pty Ltd Obesity-related genes
DE10352510A1 (en) * 2003-11-07 2005-06-23 Forschungsinstitut Für Die Biologie Landwirtschaftlicher Nutztiere Method for identifying active ingredients for influencing body mass and fat intake
WO2005061711A1 (en) * 2003-12-24 2005-07-07 Samsung Electronics Co., Ltd. A polynucleotide associated with a type ii diabetes mellitus comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for analyzing polynucleotide using the same
US20080105961A1 (en) * 2004-03-16 2008-05-08 Gregory Royce Collier Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use
US20100028326A1 (en) * 2004-12-07 2010-02-04 Ohio University Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on proteins differentially expressed in serum
CN114958875B (en) * 2022-05-15 2023-08-18 赣南师范大学 Screening and application of reference gene metG of citrus yellow-long pathogen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780405B1 (en) * 1998-06-25 2001-12-28 Centre Nat Rech Scient NOVEL OLFACTORY RECEPTORS AND USES THEREOF
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides

Also Published As

Publication number Publication date
WO2003033513A1 (en) 2003-04-24
IL161294A0 (en) 2004-09-27
EP1446414A1 (en) 2004-08-18
MXPA04003635A (en) 2004-07-30
CA2463578A1 (en) 2003-04-24
EP1446414A4 (en) 2005-11-23
KR20040088019A (en) 2004-10-15
JP2005510214A (en) 2005-04-21
CN1596264A (en) 2005-03-16

Similar Documents

Publication Publication Date Title
MXPA02012749A (en) B7-like molecules and uses thereof.
MXPA02009324A (en) Product display and fronting assembly.
MXPA01007581A (en) Electronic book electronic links.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
ZA200402859B (en) Differentially expressed genes associated with obesity and type 2 diabetes.
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
HK1047130A1 (en) Sorbitol dehydrogenase, gene encoding the same and use thereof
AU2003285069A8 (en) Type 2 diabetes mellitus genes
MXPA03007270A (en) G-protein coupled receptor molecules and uses thereof.
AU1509501A (en) A novel polypeptide, a human deafness-related gene 14 and the polynucleotide encoding the polypeptide
AU2002229113A8 (en) Glucose transport-related genes and uses thereof
HUP0300813A3 (en) Genes and proteins, and their uses
HK1046027A1 (en) Hinge.
AU2003268519A1 (en) Type 2 diabetes susceptibility genes
AU2001231484A1 (en) A novel polypeptide, secp43, 32 that associates specifically with human selecnocysteine trna and the polynucleotide encoding thereof
AU2002364894A1 (en) Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
Asplund Isproblem i Barduelva
GB0105922D0 (en) Genes and proteins, and their use
AU144459S (en) Personal computer.
AU2002319017A1 (en) Obesity related genes expressed at least in the hypothalamus
Frashëri Qytetërimi islam
AU1490402A (en) A novel polypeptide - ring finger gene mid1 protein 10.56 and a polnucleotide encoding the same
EP1438407A4 (en) Obesity related genes expressed at least in the hypotalamus, liver or pancreas
ZA992031B (en) Plasminogen-related gene B polypeptides.
HK1033198A1 (en) Variable resistor.